West Nile Virus Continues To Be A Threat To Unvaccinated Horses

Main Category: Veterinary
Also Included In: Immune System / Vaccines;  Infectious Diseases / Bacteria / Viruses
Article Date: 07 Apr 2007 - 0:00 PDT

email to a friend   printer friendly   opinions  

With spring here and temperatures on the rise throughout the country, growing mosquito populations increase the risk for deadly mosquito-borne diseases, including West Nile virus and equine encephalomyelitis (Sleeping Sickness). To protect their horses from these diseases, owners are encouraged to vaccinate as part of a comprehensive prevention program.

Unseasonably warm winter weather, which has been experienced in many parts of the country, may lead to an increased threat of West Nile virus. The first case of equine West Nile in 2007 was reported in Sonoma County, Calif., in February - much earlier than recent years - and at least six counties in California have already reported West Nile virus activity. West Nile virus is considered endemic in all areas of the country and poses a major health threat to humans, horses and other animals.

"Because it isn't headline news anymore and because it's been around for several years, many horse owners believe West Nile virus is no longer a threat to their horses," says Tom Lenz, DVM, Vice President of Professional Services at Fort Dodge Animal Health. "This is not true. More than 1,000 horses were diagnosed with the disease last year, with some states reporting more than 50 cases. It is still a serious equine health issue and all horses should be vaccinated."

For more than five years, veterinarians and horse owners across the country have relied on West Nile-Innovator(R) from Fort Dodge Animal Health to protect horses from West Nile virus. The United State Department of Agriculture has credited West Nile-Innovator with contributing to the 70 percent decline in U.S. equine West Nile cases at the height of the epidemic. West Nile-Innovator is the No. 1 choice among veterinarians with more than 23 million doses of the vaccine administered nationwide and nine out of 10 horses vaccinated against West Nile receive West Nile-Innovator.

Guidelines from the American Association of Equine Practitioners (AAEP) state proper vaccination of previously non-vaccinated horses involves administration of two doses of vaccine three to six weeks apart. Revaccination is best completed in the spring, prior to the onset of mosquito season; however, veterinarians in some areas of the country recommend boostering more than once a year based on the geographic risk. Horse owners should contact their veterinarian as soon as possible to evaluate threat levels in their area and determine their horse's current vaccination status, to ensure they will have maximum protection against the disease.

Fort Dodge Animal Health, a division of Wyeth (NYSE: WYE), is a leading manufacturer and distributor of animal health products for the equine, livestock, companion animal, swine and poultry industries in North America and international markets. As a committed partner to veterinary practitioners, horse and pet owners, and livestock producers worldwide, Fort Dodge is making a difference in the future of animal health through innovative research and product development that address current and emerging animal health needs. Key products include West Nile-Innovator(R) and Innovator(R) combination vaccines, Fluvac Innovator(R) vaccines and QUEST(R) Gel.

Fort Dodge Animal Health, Division of Wyeth
http://www.wyeth.com

• Additional
• References
• Citations